SCHEMBL3360875

SCHEMBL3360875

CCCCCCCOC1CCC(OC(=O)c2ccc(C=CC(=O)O)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
HTT P42858 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.40
ESR1 P03372 1/20 0.39
PGR P06401 1/20 0.39
ESR2 Q92731 1/20 0.39
BCHE P06276 3/20 0.39
ACHE P22303 2/20 0.39
APP P05067 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
CASP3 P42574 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3357841 1.00 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3357846 1.00 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3356919 1.00 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3360871 1.00 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3356921 1.00 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3358108 0.99 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3358105 0.99 ALDH1A1 (0.42) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3355231 0.95 ABCG2 (0.44) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3355236 0.95 ABCG2 (0.44) ALDH1A1HTTABCG2ESR1PGR
SCHEMBL3356721 0.91 KDM4E (0.43) ALDH1A1HTTABCG2ESR1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
EP-2152660-B1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2016-05-11 EP disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 ALDH1A1 97/4885HTT 2266/4885ABCG2 3592/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 ALDH1A1 97/4885HTT 2266/4885ABCG2 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.